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Histone methylation regulates chromatin struc-
ture, transcription, and epigenetic state of the
cell. Histone methylation is dynamically regu-
lated by histone methylases and demethylases
such as LSD1 and JHDM1, which mediate
demethylation of di- and monomethylated his-
tones. It has been unclear whether demeth-
ylases exist that reverse lysine trimethylation.
We show the JmjC domain-containing protein
JMJD2A reversed trimethylated H3-K9/K36 to
di- but not mono- or unmethylated products.
Overexpression of JMJD2A but not a catalyt-
ically inactive mutant reduced H3-K9/K36 tri-
methylation levels in cultured cells. In contrast,
RNAidepletionof theC.elegansJMJD2Ahomo-
log resulted in an increase in general H3-K9Me3
and localized H3-K36Me3 levels on meiotic
chromosomes and triggered p53-dependent
germline apoptosis. Additionally, other human
JMJD2 subfamily members also functioned as
trimethylation-specific demethylases, convert-
ing H3-K9Me3 to H3-K9Me2 and H3-K9Me1,
respectively. Our finding that this family of de-
methylases generates different methylated
states at the same lysine residue provides a
mechanism for fine-tuning histone methylation.
INTRODUCTION
The N-terminal tails of histones are subject to a plethora of
posttranslational modifications including phosphorylation,
ubiquitination, acetylation, and methylation. Each modifi-cation can affect chromatin architecture, but the total
sum of these modifications may be the ultimate determi-
nant of the chromatin state, which governs gene transcrip-
tion (Jenuwein and Allis, 2001; Strahl and Allis, 2000). His-
tonemethylation has been implicated inmultiple biological
processes including heterochromatin formation, X-inacti-
vation, genomic imprinting, and silencing of homeotic
genes (Kouzarides, 2002; Lachner and Jenuwein, 2002;
Margueron et al., 2005; Martin and Zhang, 2005). Aberrant
histonemethylation has been linked to a number of human
diseases such as cancer (Fraga et al., 2005; Hake et al.,
2004; Schneider et al., 2002; Varambally et al., 2002;
Hess, 2004a; Okada et al., 2005). Methylation occurs on
both lysine (K) and arginine (R) residues. Five K residues
on the tails of histone H3 and H4 (H3-K4, H3-K9, H3-
K27, H3-K36, and H4-K20) as well as K79 located within
the core of histone H3 have been shown to be sites for
methylation (Margueron et al., 2005; Zhang and Reinberg,
2001). Methylation at these sites has been linked to both
transcriptional activation and repression, as well as DNA-
damage response (Sanders et al., 2004; Zhang and Rein-
berg, 2001), demonstrating a widespread role for histone
methylation in various aspects of chromatin biology (Mar-
tin andZhang, 2005). Lysine residues can bemono-, di-, or
trimethylated. These differentially methylated lysine resi-
dues may serve as docking sites for different effector pro-
teins and/or platforms for chromatin modifiers including
histone methylases, deacetylases, or remodeling activi-
ties, which may result in potentially diverse functional out-
comes and underscore the complexity of methylation
regulation.
Euchromatic histone methylation can contribute to ei-
ther transcriptional activation or repression. In general,
methylation at histone H3-K4 and H3-K36, including di-
and trimethylation at these sites, has been linked to ac-
tively transcribed genes (reviewed in Martin and Zhang
[2005]). In contrast, H3-K9 promoter methylation isCell 125, 467–481, May 5, 2006 ª2006 Elsevier Inc. 467
considered a repressive mark for euchromatic genes
(Nielsen et al., 2001; Shi et al., 2003) and is also one of
the landmark modifications associated with heterochro-
matin (Nakayama et al., 2001; Peters et al., 2002; Rea
et al., 2000). Interestingly, a recent study identified associ-
ation of H3-K9 trimethylation (H3-K9Me3) with actively
transcribed genes as well (Vakoc et al., 2005). The differ-
ence appears to lie in the location of H3-K9Me3, i.e., ac-
tively transcribed genes are enriched for H3-K9Me3 within
the coding region (Vakoc et al., 2005). Thus,methylation at
different lysine residues, degrees of methylation at the
same lysine residue, as well as the locations of themethyl-
ated histone within a specific gene locus, can impact tran-
scriptional and biological outcomes.
Unlike other histone modifications such as acetylation,
methylation has long been considered a ‘‘permanent’’
modification. This view was based on the earlier observa-
tion that the half-lives of histones and total histone methyl
groups were comparable, which led to the conclusion that
histone methylation is stable and irreversible (Byvoet
et al., 1972; Thomas et al., 1972). However, the identifica-
tion of the H3-K4-specific histone demethylase LSD1
challenged this view and suggested that histone methyla-
tion is reversible and dynamically regulated (Shi et al.,
2004). When in complex with the androgen receptor,
LSD1 has also been shown to demethylate H3-K9Me2,
expanding the substrate repertoire of LSD1 (Metzger
et al., 2005). The LSD1 protein interactions have also
been shown to play a key role in either facilitating or inhib-
iting demethylation ofmore complex substrates (Lee et al.,
2005; Shi et al., 2005). Importantly, the finding that LSD1
mediates demethylation via a FAD-dependent oxidative
reaction predicts that nuclear proteins that are capable
of mounting an oxidative reaction of the N-methylated
proteins are possible candidates for histone demethyl-
ases (Shi et al., 2004). Consistent with this, a second his-
tone demethylase, JHDM1, has been recently reported
(Tsukada et al., 2006). JHDM1 specifically demethylates
H3-K36Me2 via an oxidative reaction catalyzed by the
evolutionarily conserved JmjC domain, although the de-
tailed chemical mechanism differs from that of LSD1 (Tsu-
kada et al., 2006). Both LSD1 and JHDM1 demethylate
only di- or monomethylated histones. The inability of
LSD1 to demethylate trimethylated histone is due to its in-
herent chemistry, i.e., LSD1 requires protonated nitrogen
in the substrate for the demethylation reaction to occur,
thus precluding trimethylated proteins as its substrates.
JHDM1, however, uses Fe(II) and a-ketoglutarate as co-
factors to mediate a hydroxylation-based demethylation
and therefore does not require protonated nitrogen for de-
methylation. The basis for the preference of JHDM1 for
mono- and di- but not trimethylated substrates remains
to be determined. Collectively, these findings raise the
possibility that trimethylation either represents a perma-
nent modification or its reversal may involve yet-to-be-
identified histone demethylases.
The JmjC domain is conserved from bacteria to eukary-
otes and belongs to the cupin superfamily of metalloen-468 Cell 125, 467–481, May 5, 2006 ª2006 Elsevier Inc.zymes. There are over 100 JmjC domain proteins across
the evolutionary phyla and essentially all of them are pre-
dicted to be enzymes (Clissold and Ponting, 2001). JmjC
domains can mediate radical-based oxidative reactions
(hydroxylation) and are chemically compatible with de-
methylation of trimethylated substrates. In search for a tri-
methylation-specific histone demethylase, we used a can-
didate approach and focused on approximately 28 human
JmjC domain-containing proteins. In this report, we pro-
vide evidence that a subset of these JmjC proteins, i.e.,
the JMJD2 subfamily, are histone lysine trimethyl de-
methylases. The JMJD2 family is composed of four mem-
bers (JMJD2A, JMJD2B, JMJD2C, and JMJD2D); Katoh,
2004). JMJD2A has recently been shown to interact with
the tumor suppressor Rb, histone deacetylases (HDACs),
and the corepressor N-CoR and functions as a repressor
in part through the recruitment of HDACs and N-CoR,
respectively (Gray et al., 2005; Yoon et al., 2003; Zhang
et al., 2005). However, molecular mechanisms by which
JMJD2A represses transcription are incompletely under-
stood. JMJD2C is also known as GASC-1 (gene amplified
in squamous cell carcinoma) and has been implicated in
tumorigenesis (Yang et al., 2000). Essentially nothing
was known about JMJD2B and JMJD2D.
We show that JMJD2A is a lysine trimethyl-specific his-
tone demethylase, which catalyzes demethylation of H3-
K9Me3 and H3-K36Me3, but not mono, di-, or trimeth-
ylated H3-K4, H3-K27, and H4-K20. JMJD2A converts
H3-K9/36Me3 to H3-K9/36Me2 but not H3-K9/36Me1 or
unmethylated products. Consistent with these observa-
tions, overexpression of JMJD2A results in a reduction
of H3-K9/36Me3 in cultured cells. Furthermore, RNAi de-
pletion of the C. elegans JMJD2A homolog (ceJMJD2)
causes a localized H3-K36Me3 increase on the X chromo-
some and higher H3-K9Me3 levels on meiotic chromo-
somes in the adult hermaphrodite germline. In addition,
we observed increased germ cell apoptosis consistent
with the activation of a DNA-damage checkpoint. Collec-
tively, these findings provide strong evidence that
JMJD2A is a lysine trimethyl-specific demethylase that
may play an important role in development. We further
demonstrated that the other human JMJD2 family mem-
bers are mainly trimethyl-specific histone demethylases
as well. Our findings identify a family of enzymes that
specifically reverse trimethylated histones and demon-
strate the importance of these enzymes in a multicellular
organism.
RESULTS
JMJD2A Is a KMe3-Specific Demethylase
JMJD2A is a member of the JMJD2 subfamily of JmjC do-
main-containing proteins and is evolutionarily conserved
from C. elegans to human (Figure 1). All four members
contain the JmjC domain, which is predicted to be ametal-
loenzyme catalytic motif (Clissold and Ponting, 2001).
JMJD2E and -2F were previously reported to bemembers
of this family (Katoh, 2004), which are intronless genes
Figure 1. Schematic Representation of
the JMJD2 Family
A phylogenic tree and diagrammatic represen-
tation of the JMJD2 family and their associated
conserved protein domains as determined by
the SMART program. The only C. elegans
JMJD2 protein (Y48B6A.11) is schematically
represented as well. The human andC. elegans
proteins were compared to one another using
DRAWGRAM (Biology WorkBench 3.2-DRAW-
GRAM; Felsenstein, 1989). The scale bar corre-
sponds to 145 amino acids.located adjacent to jmjd2d. It remains unclear whether
they are functional genes as they are not represented by
any current human ESTs. The JMJD2 family members
also contain the JmjN domain, which is conserved among
a subset of JmjC domain proteins. With the exception of
JMJD2D, the other three members contain two PHD and
Tudor domains, which are found in many proteins associ-
ated with chromatin and transcriptional regulation. The
Tudor domain of JMJD2A has recently been shown to
bind H3-K4Me3, H3-K9Me3, as well as H4-K20Me3 and
H4-K20Me2 in vitro (Kim et al., 2006); however, the func-
tional significance of this binding remains unclear. Phylo-
genic analysis of the first 350 amino acids for this subfam-
ily, which contain both the JmjN and JmjC domains,
shows that JMJD2A and -2C are more similar to one an-
other than JMJD2B and -2D. They all contain the con-
served amino acids that are associated with Fe(II) coordi-
nation (see Figure S1 in the Supplemental Data available
with this article online; Lee et al., 2003).
To determine whether JMJD2A is a histone demeth-
ylase, we isolated a full-length JMJD2A cDNA from HeLa
cells by RT-PCR, subcloned it into aGateway entry vector,
and subsequently transferred it to expression vectors
used to purify the recombinant protein from insect Sf9
cells to near homogeneity (Figure S2). In order to deter-
mine whether JMJD2A had histone demethylase activity,
we used a MALDI-TOF mass spectrometric approach to
screen for demethylation using a variety of histone pep-
tides representing mono-, di-, and trimethylation for at
least five different H3 lysine residues. With this approach,
we were able to detect enzymes with low levels of de-
methylation activity. As shown in Figure 2, JMJD2A medi-
ated demethylation at two of the five sites tested, namely
H3-K9 and H3-K36, but not H3-K4, H3-K27, and H4-K20.
Importantly, JMJD2A appeared to specifically demethyl-
ate H3-K9Me3 and H3-K36Me3 (Figure 2, shaded panels),but not H3-K9/K36Me2 or H3-K9/K36Me1. Furthermore,
the demethylation reaction of H3-K9Me3 and H3-K36Me3
only resulted in dimethylated, but no mono- or un-methyl-
ated products (Figure 2).
JmjC domain-mediated demethylation reactions re-
quire Fe(II) and a-ketoglutarate as cofactors (Tsukada
et al., 2006). As shown in Figure 3, consistent with the pro-
posed chemistry, omission of a-ketoglutarate or addition
of the iron chelator deferoxamine (DFO; 250 mM) com-
pletely inhibited the demethylation reactions mediated
by JMJD2A at both the H3-K9 and H3-K36 sites. In addi-
tion, the N-terminal 350 amino acids of JMJD2A, which in-
clude both the JmjN and JmjC domains, are sufficient to
mediate the demethylation reactions with the same site
specificity as that of the full-length JMJD2A (Figures 3
and S3). Only when excess amounts of purified JMJD2A
protein were used (75 mg) did we see low levels of de-
methylation of H3-K9Me2 or H3-K36Me2 (data not shown).
Consistent with these observations, when using bulk his-
tones as substrates, Western blot analysis also showed
robust JMJD2A-mediated demethylation at both H3-
K9Me3 and H3-K36Me3, but not H3-K9Me2 or H3-
K36Me2. However, we also noticed a slight decrease in
H3-K4me3 using the same assay conditions (Figure 3B).
The JMJD2A fragment (1–350 aa) was able to demethylate
histones but required more enzyme (at least 3-fold)
to achieve a similar decrease in H3-K9Me3 and H3-
K36Me3 signals (data not shown).
As discussed earlier, JmjC domain-containing proteins
belong to the cupin superfamily of metalloenzymes. Three
amino acids predicted to be involved in metal binding are
conserved in almost all JmjC domain proteins (Clissold
and Ponting, 2001). In JMJD2A, these three amino acids
are His 188, Glu 190, and His 276. Consistently, mutation
of H188 to alanine (A) essentially abrogated the demeth-
ylase activity of JMJD2A (Figure 3A). Taken together, ourCell 125, 467–481, May 5, 2006 ª2006 Elsevier Inc. 469
Figure 2. Identification of Histone Demethylase Activity for Full-Length JMJD2A by MALDI-TOF Mass Spectrometry
Each panel contains spectrum for either mono- (M), di- (D), or trimethylated (T) peptides (histone 3 lysines 4, 9, 27, 36, or histone 4 lysine 20; 10 mM)
incubated alone or with full-length JMJD2A (1–2 mg). The appearance of a peak corresponding to demethylated peptide is marked with a star and
a shaded panel. The shift corresponds to a loss of 14 Da because CH3 is removed and a H is added. Only trimethylated lysines 9 and 36 were
demethylated by full-length JMJD2A.in vitro analysis indicates that JMJD2A functions as a his-
tone H3-K9/36Me3 demethylase.
JMJD2A Overexpression Antagonizes H3-K9Me3
and H3-K36Me3 In Vivo
We next determined whether JMJD2A overexpression
would alter H3-K9 and H3-K36 trimethylation in vivo.470 Cell 125, 467–481, May 5, 2006 ª2006 Elsevier Inc.JMJD2A was tagged with the HA epitope (HA-JMJD2A)
and transfected into HeLa cells. Forty-eight hours
posttransfection, cells were fixed and costained with anti-
bodies recognizing the HA epitope and histone methyla-
tion at various lysine residues. As shown in Figures 4A–
4D, the signal representing H3-K36Me3 was significantly
reduced in cells where HA-JMJD2A was either highly or
Figure 3. Catalytic Activity of Full-Length
hJMJD2A and JmjN/JmjC Domains for
JMJD2A Requires Fe(II) and a-Ketogluta-
rate
(A) The full-length protein does not demethylate
either trimethylated lysine 9 or 36 when a-keto-
glutarate is omitted from the reaction. The trun-
cated protein also requires a-ketoglutarate
(data not shown). The divalent chelator EDTA
(10 mM; data not shown) and iron-specific poi-
son DFO (250 mM) inhibit the demethylation re-
action. Histidine 188 was predicted to interact
with Fe(II) and when mutated (histidine to ala-
nine; H188A) demethylase activity was abro-
gated.
(B) The full-length JMJD2A demethylates his-
tone 3 K9/36Me3 in vitro. Histone (5 mg) was in-
cubated with 1 mg of full-length JMJD2A in the
demethylase reaction buffer for 4 hr at 37ºC.
Equal amounts fromeach reactionwere probed
with H3 antibodies to H3-K4Me3, H3-K9Me2,
H3-K9Me3, H3-K36Me2, and H3-K36Me3.moderately overexpressed (marked by arrows). We
counted 166 transfected cells and found that H3-
K36Me3 levels decreased in approximately 63% of these
cells (104/166 cells; Table 1). As a control, we also exam-
ined 50 surrounding nontransfected cells and found that
the majority of these cells (90%; 45/50 cells) showed no
change in H3-K36Me3 levels (Table 1). Similarly, we also
observed a significant decrease in H3-K9Me3 level in
the HA-JMJD2A transfected cells (44% [55/124 cells]; Fig-
ures 4E–4H; Table 1). No overt changes were observed for
monomethylated H3-K9/36 as a result of overexpression
of JMJD2A; however, mild increases in dimethyl histone
3 K9/36 were observed (3.1- and 1.6-fold, respectively;
Table 1). As a further control, we showed that the H3-
K4Me3 signal was essentially unaffected, indicating sub-
strate specificity (Figures 4I–4L; 0/126 cells). Importantly,
the point mutation H188A that abrogated the demethylaseactivity of JMJD2A (Figure 3A) eliminated the ability of HA-
JMJD2A to reduce H3-K9/36 trimethylation in vivo (6/80
and 1/74 cells, respectively; Table S1), suggesting that
the loss of the trimethylation signals was likely due to de-
methylation (Figures 4M–4P). Taken together, these find-
ings provide in vivo evidence that JMJD2A antagonize tri-
methylation at H3-K9 and H3-K36, likely via enzymatic
demethylation.
RNAi-Mediated Depletion of the C. elegans JMJD2A
Homolog Results in Increased H3-K36Me3 and
H3-K9Me3 Levels in the Adult Germline
To further examine whether JMJD2A affects H3-K9/36 tri-
methyl demethylation in vivo, we analyzed the highly con-
served C. elegans homolog (Y48B6A.11). In C. elegans,
there are two JmjN/JmjC domain-containing proteins.
Only Y48B6A.11 is a member of the JMJD2 family andCell 125, 467–481, May 5, 2006 ª2006 Elsevier Inc. 471
Figure 4. Overexpression of Full-Length hJMJD2A Results in Decreased H3-K9Me3 and H3-K36Me3 in HeLa Cells
(A–D) Moderate to high overexpression of HA-tagged JMJD2A causes decreased levels of H3-K36Me3. The loss of H3-K36Me3 is indicated with an
arrow. The demethylation activity was lost when histidine 188 was mutated to alanine (H188A; [M] and [N]). HA-JMJD2A relocalizes during mitosis
(arrowhead, [A]).
(E–H) High levels of HA-JMJD2A cause a loss of H3-K9Me3 in HeLa cells. The loss of K9Me3 is marked with arrows. The effect that HA-JMJD2A had
on H3-K9Me3 was lost when histidine 188 was mutated to alanine (H188A; [O] and [P]).
(I–L) Overexpression of HA-JMJD2A had no effect on histone 3 lysine 4 trimethylation in HeLa cells. The green corresponds to anti-HA; the red cor-
responds to the specific antibody; the blue corresponds to DAPI. The effect of HA-JMJD2A was specific for H3-K9/36Me3 (see Tables 1 and 2).has a high sequence and domain similarity to JMJD2A-D
(named ceJMJD2; Figures 1 and S1). We developed an
RNAi feeding strategy that successfully knocked down
ceJMJD2 transcripts (Figure S4A) and observed an in-
crease in germ cell apoptosis (section below). Since the
C. elegans germline was affected by the depletion of
ceJMJD2, we investigated whether there were alterations
in both K9Me3 and K36Me3 in the germline of ceJMJD2
(RNAi) animals. In wild-type N2 worms, H3-K36Me3 stain-
ing is observed over the entire length of the autosomes
throughout meiotic prophase. H3-K36Me3 staining on
the X chromosome tip occurred infrequently and was re-
stricted to one end during early meiotic prophase (i.e.,
transition zone to mid-pachytene nuclei). During late-
pachytene and early-diplotene, staining of the X becomes
gradually more extensive, eventually completely extend-
ing along the entire length of the X chromosome in all
meiocytes (data not shown). We confirmed the X chromo-
some identity by using combined anti-H3-K36Me3, DAPI,
and X FISH probe staining (Figure S4C). In the ceJMJD2
(RNAi) animals, we observed a 3-fold increase in the num-
ber of mid-pachytene nuclei carrying H3-K36Me3 staining472 Cell 125, 467–481, May 5, 2006 ª2006 Elsevier Inc.on the tip of the X chromosome (zone 5; Figure S4B; n =
83/117, where n = number of nuclei carrying a stained X
chromosome/total number of nuclei analyzed) when com-
pared with the controls (n = 31/123; Figures 5A and 5B).
In addition to the localized, increased frequency of
H3-K36Me3 X chromosome staining, we observed an in-
crease in H3-K9Me3 signal in all meiocytes throughout
prophase (Figure 5C and data not shown). Wild-type or
control (RNAi) worms have a limited number of H3-
K9Me3 foci, whereas ceJMJD2 (RNAi) worms had more
abundant, broadly distributed H3-K9Me3 foci along the
chromosomes in the germline nuclei (Figure 5C). We
also noted significantly more condensed nuclei (as deter-
mined by DAPI stained morphology) with high levels of
H3-K9Me3 staining at late-pachytene (Figures 5C and
5D; arrow). The condensed nuclei occurred at a higher fre-
quency upon ceJMJD2 (RNAi), as many as thirteen times
per gonad arm. In contrast, the number of condensed
nuclei in the control gonad arms never exceeded five per
gonad (Figure 5D). We stained for H3-K9Me2 and did
not observe significantly different patterns or levels in
RNAi treated worms (data not shown).
Table 1. JMJD2A Overexpression Results in Decreased Histone 3 Lysine 9 and 36 Trimethylation
Mono- Di- Tri-
HA-JMJD2A No Expression HA-JMJD2A No Expression HA-JMJD2A No Expression
Histone 3 Lysine 36 Methylation
No change 93.0% (80/86) 91.9% (57/62) 87.7% (128/146) 92.3% (60/65) 33.70% (56/166) 82% (41/50)
Increase 7.0% (6/86) 6.5% (4/62) 12.3% (18/146) 7.7% (5/65) 3.70% (6/166) 8% (4/50)
Decrease 0% (0/86) 1.6% (1/62) 0% (0/146) 0% (0/65) 62.70% (104/166) 10% (5/50)
Histone 3 Lysine 9 Methylation
No change 97.3% (106/109) 96.5% (55/57) 81.3% (126/155) 94.0% (47/50) 54.8% (68/124) 100% (50/50)
Increase 0.9% (1/109) 3.5% (2/57) 18.7% (29/155) 6.0% (3/50) 0.8% (1/124) 0% (0/50)
Decrease 1.8% (2/109) 0% (0/57) 0% (0/155) 0% (0/50) 44.6% (55/124) 0% (0/50)
Histone 3 Lysine 4 Methylation
No change 96.2% (49/51) 96.8% (62/64) 97.3% (109/112) 98.0% (98/100) 98.4% (124/126) 100% (50/50)
Increase 1.9% (1/51) 1.6% (1/64) 2.7% (3/112) 2.0% (2/100) 1.6% (2/126) 0% (0/50)
Decrease 1.9% (1/51) 1.6% (1/64) 0% (0/112) 0% (0/100) 0% (0/126) 0% (0/50)
Cells were transfected with a HA-tagged JMJD2A for 48 hr before being fixed, stained for the indicated antibodies, and analyzed by
fluorescence microscopy. Cells that were expressing moderate to high levels were scored for the level of histone 3 K4, 9, and 36
methylation (mono-, di-, and tri-). At the same time, nontransfected cells on the same slide were counted for changes inmethylation
status as well.Depletion of ceJMJD2 IncreasesGermline Apoptosis
and RAD-51 Staining
The condensed nuclei, based on their DAPI-stained ap-
pearance, levels, and location in the C. elegans germline
have been previously attributed to germ cell apoptosis
(Gumienny et al., 1999; Colaiacovo et al., 2003). For this
reason, we further tested the effect of ceJMJD2 depletion
on germ cell apoptosis inC. elegans. Using both Nomarski
optics and acridine orange (AO) staining, the total number
of germ cell corpses in the late-pachytene region were
scored (Figures 6A–6I). The control treated worms had
a normal level of germ cell death (3.32 ± 0.21 germ cell
corpses/gonad arm; Gumienny et al., 1999); however,
in contrast, the age-matched RNAi-treated worms had
9.24 ± 0.39 germ cell corpses/gonad arm (3-fold in-
crease, p < 0.0001; Figures 6A–6I).
DNA damage resulting from unrepaired meiotic double-
strand breaks (DSBs) or genotoxic stress has been pre-
viously shown to trigger a pachytene DNA-damage
checkpoint leading to increased germ cell apoptosis in
late-pachytene (Gartner et al., 2000). In the C. elegans
germline, DNA damage-induced, but not physiological
apoptosis, requires the functional p53 homolog, CEP-1
(Derry et al., 2001; Schumacher et al., 2001; Schumacher
et al., 2005). We found that the significant increase in ap-
optosis observed with ceJMJD2 (RNAi) was abrogated in
the cep-1 (lg12501) deletion mutant (Schumacher et al.,
2005), suggesting a link between ceJMJD2 andDNAdam-
aged-induced apoptosis (cep-1 (lg12501); control (RNAi)
had 3.15 ± 0.27 germ cell corpses/gonad arm and cep-1
(lg12501); ceJMJD2 (RNAi) had 3.5 ± 0.28 germ cell
corpses/gonad arm; Figure 6I).Given that we observed increased H3-K9Me3 and
-K36Me3 staining in the pachytene regions typically asso-
ciated with meiotic DSB repair and concomitant increase
in p53-dependent germ cell apoptosis, we next investi-
gated the possibility that depletion of ceJMJD2 by RNAi
may have contributed to an increase in DSB or delayed re-
pair by examining the number of RAD-51 foci per nucleus
at mid-pachytene (Colaiacovo et al., 2003). RAD-51 is
a member of the highly conserved RecA protein family in-
volved in strand invasion/exchange during DSB repair
(Rinaldo et al., 1998; Takanami et al., 1998; Sung, 1994).
Given that RAD-51 associates with 30 ssDNA overhangs
after DSB formation, RAD-51 foci reflect nascent recombi-
nation intermediates. Analysis of both RAD-51 levels and
temporal distribution throughout the germline allows for
monitoring the progression of meiotic recombination
(Alpi et al., 2003; Colaiacovo et al., 2003). As shown in Fig-
ure 6, there was a significant increase in the percentage of
nuclei in mid-pachytene that contained a higher number of
RAD-51 foci (Figures 6J–6L). We observed as many as 22
RAD-51 foci per nucleus in the RNAi treated worms (with
47.3% of the 165 nuclei examined carrying R9 RAD-51
foci/nucleus) compared with three to eight RAD-51 foci
per nucleus in the control animals (with only 26.8% of
the 184 nuclei examined carriedR9 RAD-51 foci/nucleus;
Figure 6L). The elevated RAD-51 foci levels may reflect ei-
ther an increase in the levels of DSBs or a delay in repair.
As in the control, the number of RAD-51 foci decreased in
ceJMJD2 (RNAi)worms during late-pachytene. Moreover,
RAD-51 foci were no longer apparent in either early dip-
lotene or diakinesis oocytes (data not shown), which
suggests that DSBs were eventually being repaired.Cell 125, 467–481, May 5, 2006 ª2006 Elsevier Inc. 473
Figure 5. Depletion of the C. elegans JMJD2A Homolog Y48B6A.11 Increases Trimethylated Histone 3 lysine 9 and 36 In Vivo
(A) After ceJMJD2 (RNAi), the frequency of X chromosome H3-K36Me3 staining increases in mid-pachytene nuclei. The left upper and lower panels
are highmagnification images of the mid-pachytene nuclei that are stained with anti-K36Me3 alone. The right panels show amerge of DAPI (blue) and
anti-K36Me3 (red). The arrow indicates the unstained X chromosome in the control. Arrowheads indicate the stained X chromosome tip in RNAi-
treated worms.
(B) A graphical representation of the increased percentage of X chromosome staining in mid-pachytene nuclei in ceJMJD2 (RNAi) worm gonads.
(C) Depletion of ceJMJD2 results in a concomitant increase in H3-K9Me3 foci throughout germline nuclei. These panels show late-pachytene nuclei
from either control or RNAi-treated worms stained with DAPI (blue) and anti-H3-K9Me3 (red). Enlarged nuclei are shown to the right of each panel.
RNAi cells have more abundant H3-K9Me3 foci throughout the nuclei. The condensed nuclei with increased H3-K9Me3 staining are shown with an
arrow in the control image.
(D) Graphical representation of the levels of condensed nuclei with intense K9Me3 staining (red) observed at late-pachytene. An enlarged view of this
type of nuclei can be seen in the inset indicated with an arrow. The graph demonstrated a rightward shift in the number of condensed and heavily
H3-K9Me3 stained nuclei per gonad after RNAi. As many as 13 nuclei/gonad arm were seen in the RNAi treated worms, which contrasted with
the 5 nuclei/germline seen in control worms. Scale bar equals 2 mm.Consistently, there was no evidence of chromosome frag-
mentation in oocytes undergoing diakinesis and all six
chromosome pairs remained attached through chias-
mata, indicating successful crossover formation (data
not shown). Taken together, we demonstrated that alter-
ations in the H3-K9 and -K36 trimethylation status in the
ceJMJD2 (RNAi) germline coincides with significantly in-
creased CEP-1/p53-dependent germ cell apoptosis and
altered progression of meiotic DSB repair.
Demethylation by Other Members
of the JMJD2 Family
The finding that human JMJD2A is a histone demethylase
prompted us to investigate whether the other three closely
related family members in human, JMJD2B, JMJD2C, and
JMJD2D are histone lysine demethylases as well. The474 Cell 125, 467–481, May 5, 2006 ª2006 Elsevier Inc.cDNAs encoding the first 350 amino acids of JMJD2B,
-2C, and -2D, which include both the JmjN and JmjC do-
mains (Figures 1 and S1), were subcloned into a HIS
epitope-tag expression vector and purified from bacteria.
As shown in Figure S5, mass spectrometry analysis re-
vealed demethylation of H3-K9Me3mediated by JMJD2C
and JMJD2D but very weak demethylation by JMJD2B.
JMJD2C also exhibited demethylation activity toward
H3-K36Me3, but none of these proteins showed any activ-
ity toward other methylated sites including H3-K4, H3-
K27, H3-K79, andH4-K20 (Figure S5 and data not shown).
While JMJD2C only generated H3-K9Me2, JMJD2D
converted H3-K9Me3 to H3-K9Me2 and H3-K9Me1. Con-
sistently, JMJD2D was the only member that demethyl-
ated H3-K9Me2. Under our assay conditions, we never
observed complete demethylation of the substrates. The
Figure 6. Depletion of ceJMJD2 Leads to Increased Apoptosis and Elevated Levels of RAD-51 Foci
(A–I) Depletion of ceJMJD2 caused a significant increase in the number of germ cell corpses observed at late pachytene. Nomarski optics view shows
the germ cell corpses in both control ([A] and enlarged view in [G], arrow) and RNAi-treated worms ([B] and enlarged view in [H], arrows).
(C and D) There are increased numbers of acridine orange positive cells in RNAi-treated worms (D) compared to the control worms (C). (E) and
(F) show a merge of the acridine orange staining on the Nomarski image.
(I) A graphical representation of the mean number of germ cell corpses from two to five separate experiments. There is a 2.8-fold increase in germ cell
apoptosis in ceJMJD2 (RNAi)-treated worms (p < 0.0001); however, in the cep-1 (lg12501) strain, the amount of apoptosis was dramatically reduced.
(J–L) Levels of RAD-51 foci were elevated in mid-pachytene nuclei in ceJMJD2 (RNAi) worms.
(J and K) These panels represent mid-pachytene nuclei (zone 5; see Figure S5) from whole-mount preparations stained with DAPI (blue) and with
RAD-51 (red).
(L) Graphical representation of the quantitation of the observed numbers of RAD-51 foci/nucleus in zone 5 for both control and RNAi animals. RNAi led
to an observable increase in the overall percentage of nuclei withR9 RAD-51 foci compared to control.results of these analyses are summarized in Table 2. In
summary, we have demonstrated that the JMJD2 family
members are histone demethylases that are mainly in-
volved in demethylation of trimethylated H3-K9 and -K36.
DISCUSSION
Histone methylation represents a fascinating posttransla-
tional modification with multiple layers of complexity that
suggest a very important role in chromatin biology. We
have provided a number of new and important insights
into histone methylation regulation. First, we have shown
that trimethylation is dynamically regulated by specific de-
methylases as previously described for di- and mono-
methylation (Shi et al., 2004; Tsukada et al., 2006). Sec-
ond, we demonstrated that the JMJD2 family of proteins
have the ability to generate different states of methylation
at H3-K9 (di- versus monomethylation), suggesting a
mechanism for fine-tuning histone methylation. Third, assuggested by the findings in C. elegans, we have demon-
strated that these proteins are likely to play important bi-
ological roles in multicellular organisms.
Dynamic Regulation of Histone Lysine
Trimethylation by Demethylases
Multiple lines of evidence suggest that histone lysine tri-
methylation plays an important role in chromatin biology.
Trimethylation at H3-K9 and H4-K20 has been shown to
be associated with constitutive heterochromatin (Schotta
et al., 2004b), while H3-K9Me2 and K9Me3, along with
H3-K27Me3 have been associated with X inactivation
(Bean et al., 2004; Cowell et al., 2002; Kelly et al., 2002;
Reuben and Lin, 2002; Rougeulle et al., 2004; Plath
et al., 2003). However, H3-K9Me3 in the gene-coding re-
gions is associated with transcriptional elongation (Vakoc
et al., 2005), while, H3-K36Me2/3 plays an important role
in suppressing inappropriate transcription within the body
of genes (Carrozza et al., 2005; Joshi and Struhl, 2005;Cell 125, 467–481, May 5, 2006 ª2006 Elsevier Inc. 475
Keogh et al., 2005). Enzymes that are responsible for tri-
methylation at many of these sites have been identified
(as reviewed in Margueron et al. [2005]; Sun et al., 2005;
Zhang and Reinberg, 2001). However, virtually nothing
was known about the trimethylation dynamics associated
with these or other methylated histones in eukaryotes.
The identification of the H3-K9 and H3-K36 trimethyl de-
methylases in this study supports the dynamic nature of
regulation of histone trimethylation. In the case of the tran-
scriptional corepressor JMJD2A, its ability to demethylate
H3-K36Me3 and H3-K9Me3 suggests its involvement in
transcriptional and posttranscriptional regulation. The role
of JMJD2A in these processes may be in addition to, or
separate from, the repression activity associated with
the recruitment of Rb or the corepressor N-CoR described
previously (Gray et al., 2005; Yoon et al., 2003; Zhang
et al., 2005).
The ability of JMJD2A to demethylate both H3-K9Me3
and H3-K36Me3 was somewhat unexpected, given that
both LSD1 and JHDM1 are highly site specific. Impor-
Table 2. JMJD2 Family Demethylate Histone 3 K9
and/or K36
JMJD2A JMJD2B JMJD2C JMJD2D
H3-K4Me3    
H3-K4Me2    
H3-K4Me1    
H3-K9Me3 ++ + ++ ++
H3-K9Me2 +/a   ++
H3-K9Me1    
H3-K27Me3    
H3-K27Me2    
H3-K27Me1    
H3-K36Me3 ++  ++ 
H3-K36Me2 +/a   
H3-K36Me1    
H3-K79Me3    
H3-K79Me2    
H3-K79Me1    
H4-K20Me3    
H4-K20Me2    
H4-K20Me1    
The data in this table were collected by MALDI-TOF mass
spectrometry. In each condition 5–7 mg of purified protein
(1–350 aa) was added to each reaction (see Experimental
Procedures). In each case, 10 mM of peptide for the indicated
modifications was added to the reaction at 37ºC for 2–5 hr.
Each experiment was conducted at least two independent
times.
a This activity was only observed with 75 mg of protein.476 Cell 125, 467–481, May 5, 2006 ª2006 Elsevier Inc.tantly, the cell culture and C. elegans results provided in
vivo evidence supporting this possibility (Figures 4–6; Ta-
ble 1). However, it remains to be determined whether
JMJD2A (and JMJD2C) may kinetically favor one site
over the other in vivo. In addition, one can not exclude
the possibility that these proteins may display altered
site specificities in vivo when complexed with different
proteins, as has been reported for LSD1 (Metzger et al.,
2005; Shi et al., 2005).
Mass spectrometry analysis indicated that JMJD2A
converts H3-K9/36Me3 to H3-K9/36Me2 but not H3-K9/
36Me1 or unmethylated products (Figures 2 and 3).
Thus, a decrease in trimethylation in vivo is predicted to
result in an increase in dimethylation at the same site.
We observe a slight increase in H3-K9/K36Me2 levels in
the JMJD2A-transfected cells; however, we did not detect
changes in vitro with bulk histones (Table 1; Figure 3B).
When considering mass spectrometric data from human,
mouse, and Drosophila, these observations may not be
that surprising because H3-K9Me2 constitutes as much
as 50% of the methylated H3, while mono- and trimethyl-
ation represent only 15%–20% for H3 lysine 9 (McKittrick
et al., 2004; Peters et al., 2003; Thomas et al., 2006; Zhang
et al., 2004). Therefore, a decrease in trimethylation would
not necessarily lead to an increase in dimethylation at the
same site that is easily detectable byWestern blot analysis
in vitro. Finally, in vivo we cannot exclude the possibility
that JMJD2A may be associated with additional demeth-
ylases that can convert the di- tomono- or even to unmod-
ified products.
Fine-Tuning Histone Methylation by Demethylases?
Although the JMJD2 family members all appear to be
specific for trimethylated lysine residues, they display dif-
ferential ability to mediate different degrees of demethyla-
tion. Specifically, while JMJD2A/C generates H3-K9Me2,
JMJD2D is capable of reducing H3-K9Me3 to the mono-
methylated state. Although it is formally possible that
these differences may represent in vitro peculiarities, we
believe that they provide an important mechanism for
fine-tuning methylation regulation in vivo. Similar to the
JMJD2 demethylases, there are histone methyltrans-
ferases that seem to have different capabilities in adding
one to three methyl groups per lysine (Kouzarides, 2002;
Lachner and Jenuwein, 2002; Margueron et al., 2005;
Zhang and Reinberg, 2001). Importantly, loss of the H3-
K9Me3-specific methylase Suv39h results in the specific
accumulation of H3-K9Me1, while a loss of G9a causes
a loss of mono- and dimethylation and but retention of tri-
methylation, consistent with the potential importance of
differential methylation states at the same lysine residue
(Peters et al., 2001; Rice et al., 2003). In addition, previous
studies have documented that differential methylation
levels at the same sites appear to be associated with dif-
ferent chromosomal regions. For instance, H3-K27Me3 is
associated with an inactive X chromosome (Fong et al.,
2002; Kelly et al., 2002; Reuben and Lin, 2002; Plath
et al., 2003; Rougeulle et al., 2004), but H3-K27Me1 is
enriched at pericentric heterochromatin on mitotic chro-
mosomes (Peters et al., 2003). While H3-K9Me3 is also
linked to pericentric heterochromatin, H3-K9Me1 and
H3-K9Me2 are associated with euchromatin silent do-
mains (Peters et al., 2003; Rice et al., 2003).
Recently, Vakoc et al. (2005) demonstrated that tran-
scriptionally active genes had increased levels of H3-
K9Me3 in their coding regions. This observation is consis-
tent with the observed increase of HP1 and H3-K9Me3
staining in heat-shocked genes in Drosophila polytenes
(Piacentini et al., 2003). These data suggest a correlation
between H3-K9 trimethylation and active gene transcrip-
tion. Previous studies linked H3-K36Me2/Me3 to tran-
scriptional elongation (Krogan et al., 2003; Li et al., 2003;
Schaft et al., 2003; Xiao et al., 2003). More recent studies
show that H3-K36 methylation is linked to suppression of
inappropriate transcription within the body of genes, via
recruitment of a specific deacetylase complex (Carrozza
et al., 2005; Joshi and Struhl, 2005; Keogh et al., 2005).
This mechanism may be important for resetting the chro-
matin structure to the basal, repressed transcriptional
state. Additionally, di- and trimethylated H3-K36 have
also shown to be enriched proximal to the 50 start position
of actively transcribed genes and continuing through the
30 end in both yeast and chicken, suggesting a role for
H3-K36 methylation in transcriptional termination and 30
processing (Bannister et al., 2005; Rao et al., 2005). There-
fore, fine tuning methylation at H3-K36, along with H3-K9,
could play a fundamental role in both transcriptional and
posttranscriptional regulation of gene expression. Future
experiments to identify the genomic locations of JMJD2A
and its downstream target genes will begin to elucidate
the mechanisms by which this class of demethylases
function.
Although the exact functions of differentially methylated
states are still incompletely understood, the available evi-
dence points to them being an important nexus to an in-
creased regulatory potential associated with histone
methylation (Schotta et al., 2004a). The balance between
the site-specific methylases and demethylases is ex-
pected to generate a whole array of methylation states
at various histone lysine residues, which are likely to serve
as docking sites for different effector proteins or as altered
substrates for both chromatin modifying and remodeling
enzymes (e.g., histone deacetylases and methyltrans-
ferases).
Histone Methylation/Demethylation and Their
Biological Significance
Histone methylation occurs in a host of organisms, rang-
ing from Neurospora crassa to C. elegans and to humans.
Studies inmice have demonstrated that during fertilization
and zygotic development H3-K9 methylation undergoes
dynamic changes (Sarmento et al., 2004; Yeo et al.,
2005). Similarly, C. elegans show temporal regulation of
H3methylation, wheremethylation is absent at certain de-
velopmental windows during embryogenesis but returns
as animals mature and approach the reproductive stage(i.e., K4Me3 in germline precursors; Schaner et al., 2003;
Schaner, 2006). In addition to a role in embryonic develop-
ment, methylation is also intricately associated with the si-
lencing of the X chromosome and euchromatic regions in
a number of organisms (Cowell et al., 2002; Lucchesi
et al., 2005; Rice et al., 2003; Peters et al., 2003).
H3-K9 modification has been observed associated with
a transcriptionally silent X chromosome (Kelly et al., 2002;
Reuben and Lin, 2002; Rougeulle et al., 2004). However,
H3-K36 methylation on the X chromosome has not been
analyzed. Our finding that ceJMJD2 suppresses H3-
K36Me3 on the X chromosome suggests that keeping
low, infrequent levels of K36Me3 on the X chromosome
may be important for maintaining low gene expression
during germline development (Kelly et al., 2002; Reinke
et al., 2000; Reuben and Lin, 2002). Similarly, other activat-
ing marks H3-K4Me2/Me3 are absent on the C. elegans X
chromosome until diplotene region and diakinetic oocytes
(Kelly et al., 2002; Schaner et al., 2003; Schaner, 2006),
emphasizing the importance of histone methylation regu-
lation during development.
Another important finding of this study is that overall H3-
K9Me3 signal increases in the C. elegans germline upon
depletion by RNAi, which is paralleled by an increase in
apoptosis. InC. elegans, DNA damage-induced apoptosis
is genetically distinct from either somatic cell death or
physiological germ cell death (Gartner et al., 2000; Gu-
mienny et al., 1999; Stergiou and Hengartner, 2004).
Moreover, DNA damage-induced apoptosis requires the
p53 homolog, CEP-1, and often accompanies increased
RAD-51 foci levels, which is what we have observed in
the ceJMJD2 (RNAi) animals (Derry et al., 2001; Schu-
macher et al., 2001, 2005; Colaiacovo et al., 2003). These
data suggest a link to DNA damage-induced apoptosis;
however, the exact mechanism underlying these observa-
tions requires further investigation. Our findings suggest
that an imbalance of histone methylation at H3-K9 and
possibly H3-K36 may provide an altered chromatin envi-
ronment that would affect repair either through increased
DSBs, delayed repair kinetics of break-dependent recom-
bination intermediates, and/or through downstream tran-
scriptional targets involved in DNA-damage repair. These
observations raise the possibility that alterations of the ex-
pression and/or activities of the JMJD2 family members
may contribute to human diseases such as cancer. Con-
sistent with this hypothesis, the JMJD2C gene (also called
GASC-1; Yang et al., 2000) is often amplified in squamous
cell carcinoma and desmoplastic medulloblastoma (Ehr-
brecht et al., 2006). Such a hypothesis is also supported
by the recent studies that implicate histone methylation
regulation in tumorigenesis (Canaani et al., 2004; Fraga
et al., 2005; Hess, 2004b; Jaju et al., 2001; Pogribny et al.,
2006). Collectively, these findings suggest that both
methylases and demethylases may play important roles
in tumorigenesis. Therefore, the identification of histone
demethylases provides the opportunity to investigate the
relationship of this ever-growing family of histone modify-
ing enzymes in development and human cancers.Cell 125, 467–481, May 5, 2006 ª2006 Elsevier Inc. 477
EXPERIMENTAL PROCEDURES
Expression Constructs
hJMJD2A was PCR amplified from HeLa cell cDNA using Platinum Pfx
polymerase (Invitrogen) and introduced into the Gateway Entry sys-
tem. A fully sequenced cDNA, as well as the H188A catalytic mutant
generated by PCR of this cDNA, were transferred into additional Gate-
way vectors: HA-tag and FLAG-baculovirus. The first 350 amino acids
for hJMJD2A were subcloned into the pGEX-4T2 expression con-
struct, expressed, and purified with GST beads. The cDNA corre-
sponding to the first 350 amino acids for JMJD2B, -2C, and -2D
were amplified from a mixed cDNA library using the GC-Rich kit
(Roche) and Tgo polymerase (Roche), subcloned into pET28a and se-
quenced before being transformed and expressed from Rosetta cells.
The HIS-tagged proteins were purified by Ni-NTA affinity resin (Qia-
gen). The NTA beads were washed with 20mM imidazole before being
eluted in 250 mM inidazole. The purified proteins were then dialyzed in
DeMTase buffer 1 (20 mM Tris-HCl [pH 7.3], 150 mM NaCl, 8.0% gly-
cerol, 1 mM DTT, 1 mM PMSF).
Demethylation Reactions
Purified proteins were incubated with 10 mM of peptide or 5 mg of calf
thymus type II-A histones (Sigma) in the DeMTase reaction buffer 1
(20 mM Tris-HCl [pH 7.3], 150 mM NaCl, 50 mM (NH4)2Fe(SO4)2 +
6(H2O), 1 mM a-ketoglutarate, and 2 mM ascorbic acid) for 2–5 hr at
37ºC. A total of 1–2 mg of full-length hJMJD2A or 1–7.5 mg of the N/C
domains for JMJD2A-D were added to the reactions. The reactions
were inhibited by 10 mM EDTA and 250 mM DFO (Sigma-Aldrich).
MALDI-TOF Mass Spectrometry
One microliter of the 100 ml demethylation reaction mixture was de-
salted through aC18ZipTip (Millipore). The ZipTipwas activated, equil-
ibrated, and loaded as previously described by Shi et al. (2004). The
bound material was then eluted with 10 mg/ml a-cyano-4-hydroxycin-
namic acid MALDI matrix in 70% acetonitrile/0.1% TFA before being
spotted and cocrystallized. The samples were analyzed by a MALDI-
TOF/TOF mass spectrometer (Waters) in Hidde Ploegh’s Mass Spec-
trometry facility at the Whitehead Institute (Cambridge, MA).
Cell Culture and Transfections
HeLa (ATCC) cells were cultured in DMEM (Invitrogen) supplemented
with 10% Fetalplex, 1X penicillin/streptomycin, and L-glutamine at
37ºC and 5% CO2. HeLa cells were plated on coverslips in 24-well
dishes (2.5  104 cells/well) and transfected with Lipofectamine
2000 according to the manufacturer’s instructions.
Immunofluorescence Microscopy
Seventy-two hours posttransfection (i.e., HA-JMJD2A and HA-
JMJD2A H188A), cells were fixed with 3% paraformaldehyde, per-
meabilized, and blocked (10% FBS). The coverslip was incubated
for 3 hr at room temperature with the appropriate primary antibody,
which was then washed and incubated with the corresponding sec-
ondary antibodies for 1 hr at room temperature. The coverslips were
then washed, mounted with Vectashield (Vector Laboratories), and
analyzed by fluorescence microscopy (Leica) using a 60 objective.
Images were acquired and processed with Openlab 3.1.5 software.
Primary antibodies were used at the following dilutions: 1:1000 anti-
HA (Covance monoclonal HA.11), 1:1000 anti-monomethyl H3-K4
(Upstate 07-436), 1:160000 anti-dimethyl H3-K4 (Upstate 07-030),
1:20000 anti-trimethyl H3-K4 (Upstate 07-473), 1:5000 anti-mono-
methyl H3-K9 (Upstate 07-450), 1:5000 anti-dimethyl H3-K9 (Upstate
07-441), 1:5000 anti-trimethyl H3-K9 (Upstate 07-442), 1:10000 anti-
monomethyl H3-K36 (Abcam 9048), 1:5000 anti-dimethyl H3-K36
(Upstate 07-274), 1:5000 anti-trimethyl H3-K36 (Abcam 9050). Don-
key-anti-rabbit (Molecular Probes Alexa 594) and goat-anti-mouse
(Molecular Probes Alexa 488) secondary antibodies were used at
1:2000. DAPI was used with all staining. The cells were scored based478 Cell 125, 467–481, May 5, 2006 ª2006 Elsevier Inc.on a moderately high to high level of expression, which is reflected in
Figure 4. The cells that were not positive for HA staining were used
as background controls.
General Worm Culture and Strains
Bristol N2 and cep-1 (lg12501) (Schumacher et al., 2005) worms were
utilized. C. elegans strains were cultured at 25ºC under standard con-
ditions as described by Brenner (1974).
C. elegans Immunostaining
DAPI staining and immunostaining of C. elegans germlines from both
ceJMJD2 (RNAi) and control (RNAi) age-matched worms were carried
out as described in Colaiacovo et al., (2003). Primary antibodies were
used at the following dilutions: 1:1000 for anti-trimethyl H3-K36 (H3-
K36Me3; Abcam 9050) and anti-trimethyl H3-K9 (H3-K9Me3; Upstate
07-442); 1:100 for anti-RAD-51 (a rabbit antisera described in Colaia-
covo et al. [2003]). Cy3 anti-rabbit (Jackson Immunochemicals) sec-
ondary was utilized at 1:100. Images are projections halfway through
3D data stacks of whole nuclei. Optical sections were collected at
0.2 mm intervals utilizing a Delta Vision deconvolution microscope.
C. elegans Apoptosis Assay
Germlines were examined both by acridine orange staining and No-
marski optics as in Kelly et al. (2000). The images shown in Figure 5
were acquired with a Leica DM5000 B microscope (60 objective)
and processed with Openlab 3.1.5 software. Germ cell corpses were
scored in adult hermaphrodites 54–56 hr after being plated as L1 lar-
vae on RNAi food or HB101 bacteria, corresponding to the same rela-
tive age assayed by Kelly et al. (2000). The apoptosis data represent six
experimental data sets. A total of 109 gonad armswere scored for con-
trol (RNAi) (362 germ cell corpses/109 gonads), a total of 121 gonad
arms for ceJMJD2 (RNAi) (1118 germ cell corpses/ 121 gonads), a total
of 54 gonad arms for cep-1 (lg12501); control (RNAi) (170 germ cell
corpses/54 gonads), and a total of 55 gonad arms for cep-1 (lg12501);
ceJMJD2 (RNAi) (193 germ cell corpses/55 gonads). Statistical com-
parisons between these genetic backgrounds were conducted using
the two-tailed Mann-Whitney test. ceJMJD2 (RNAi) differed signifi-
cantly from the control (RNAi), from cep-1 (lg12501); control (RNAi),
and from cep-1 (lg12501); ceJMJD2(RNAi) (p = < 0.0001), whereas
cep-1 (lg12501); ceJMJD2 (RNAi) did not differ from either control
(RNAi) or cep-1 (lg12501); control (RNAi) (p = 0.6885 and p = 0.3887,
respectively). The statistical analysis was performed using InStat3
software (http://www.graphpad.com).
Analysis of Immunostained C. elegans Meiotic Nuclei
Following image acquisition, the germlines were divided into seven
(36 mm  36 mm) zones as in Martinez-Perez and Villeneuve, (2005)
(Figure S4B). This allowed both for an inspection of the various anti-
body localization patterns observed throughout meiotic prophase, as
well as for a reproducible quantitative analysis of levels of staining
within particular stages of meiotic prophase. The data presented for
anti-H3-K9Me3 in Figure 5 was from two experimental data sets. A to-
tal of 81 and 56 different gonad arms were examined for ceJMJD2
(RNAi) and control (RNAi), respectively. Specifically, the late pachy-
tene zone (zone 7) was examined for the anti-H3-K9Me3 immunostain-
ing (Figures 5A and 5B). This corresponds to the zone where increased
levels of germ cell corpses are observed due to the activation of a late-
pachytene DNA-damage checkpoint (Colaiacovo et al., 2003; Gartner
et al., 2000; MacQueen et al., 2002) and corresponds to the region
where we observed the intensely H3-K9Me3-stained nuclei. The
data presented for H3-K36me3 corresponds to a total of 117 and
123 nuclei scored within the nine ceJMJD2 (RNAi) and control (RNAi)
germlines, respectively.
The data presented for anti-RAD-51 consists of a total of 165 and
184 nuclei scored for ceJMJD2 (RNAi) and control (RNAi) germlines,
respectively. The mid-pachytene zone (zone 5) was selected for scor-
ing levels of RAD-51 foci given that this zone is where both the total
numbers of nuclei carrying RAD-51 foci and the numbers of RAD-51
foci/nucleus are the highest in N2 (Colaiacovo et al., 2003).
Supplemental Data
Supplemental Data include five figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at
http://www.cell.com/cgi/content/full/125/3/467/DC1/.
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